Celebrating over 30 years as Europe’s flagship partnering event, BIO-Europe 2025 is set to reinforce its role as a pivotal catalyst for innovation and collaboration in the global life sciences sector. Hosted by EBD Group with support from the Biotechnology Innovation Organization (BIO), the event will take place at the Vienna Congress and Convention Center in Vienna, Austria, from November 3–5, 2025, followed by a Digital Partnering segment from November 11–12, 2025. This dual-format approach underscores its commitment to "making every connection meaningful, targeted, and geared towards achieving breakthroughs in biotech"-a mission that has defined its growth since 1995.

A Legacy of Strategic Collaboration

Since its inception, BIO-Europe has evolved from a small gathering with 97 attendees and 60 one-to-one meetings to Europe’s largest biotech partnering conference. Recent editions, such as 2024 in Stockholm, drew 5,700 attendees from 61 countries, facilitating 30,750 one-to-one meetings and hosting 189 exhibitors. This trajectory reflects its unique ability to unite all segments of the biotechnology value chain-biotech startups, established pharma firms, investors, and service providers-around the shared goal of driving business growth through strategic relationships.

Immersive Agenda: Blending Science and Culture

The 2025 agenda, inspired by Vienna’s coffeeshop culture and musical heritage, will feature three immersive tracks that explore the most pressing topics shaping biopharma’s future. Attendees can expect cutting-edge discussions on emerging scientific breakthroughs, regulatory trends, and investment strategies, designed to inform decision-making and spark new collaborations. Complementing formal sessions, renowned evening receptions at Vienna’s iconic venues will foster informal networking, mirroring the event’s tradition of merging professional engagement with cultural immersion.

Powered by Partnering Excellence

At the core of BIO-Europe’s success is partneringONE, the industry’s gold-standard meeting platform. This tool enables attendees to schedule targeted one-to-one meetings with potential partners, investors, and collaborators-both during the in-person event and the digital phase. Building on past achievements, such as 30,642 meetings in 2023, the 2025 edition aims to streamline deal-making, with thousands of licensing opportunities posted to connect innovators with resources.

Dynamic Exhibit Floor and Ecosystem Engagement

The vibrant exhibit floor will showcase innovative products, technologies, and services from across the biotech ecosystem, offering a tangible glimpse into solutions that support drug development, manufacturing, and commercialization. This space, alongside structured networking activities, ensures that attendees can engage with peers, explore partnerships, and stay abreast of industry advancements.

For stakeholders across the life sciences spectrum, BIO-Europe 2025 is more than a conference-it is a strategic platform to accelerate business goals, whether through securing investments, in-licensing assets, or forging cross-sector alliances. As it continues to blend tradition with innovation, the event remains essential for those seeking to shape the future of biotech.

For further information, please follow the BIO-Europe website: https://informaconnect.com/bioeurope